Lymph Node Dissection for Colon Cancer in Older Patients: D2 or D3?

A B S T R A C T

Background: The aim of the study is to compare the short-term and long-term results in the treatment of colon cancer in older patients with different extents of Lymph Node Dissection (LND).
Materials and Methods: A retrospective multicenter study in general surgical geriatric department and specialized coloproctological hospitals of Sechenov University was performed between 2006 and 2015. Patients aged 75 years or older who underwent stage I-III colon cancer surgical treatment were included in the study. Groups were divided according to the extent of surgery: colon resection with D3 LND formed the study group and with D2 LND - the control group.
Results: The mean age of patients in the study was 81±4 years. Charlson’s comorbidity index before surgery was higher in the D3 LND group (p <0.001). Surgical and anaesthetic risk had no significant differences between the groups (p=0.580). Operation time with D3 LND was 25 min longer than with D2 LND, with no differences in blood loss between the groups. Despite the increased surgery duration, prolonged ventilation time was similar (p=0.093). D3 LND results in increasing in postoperative morbidity (p=0.013) with no significant differences in 30-day, 90-day and 1-year mortality between the groups. D3 LND demonstrated significant improvement in five-year overall and disease-free survival. According to the multivariate analysis, male gender, stage III tumors and D2 LND increase the risk of death within five years after surgery.
Conclusion: D3 LND in colon cancer surgical treatment in older patients does not affect the 30-day, 90-day, and one-year mortality and improves five-year overall and disease-free survival.

Keywords

Colon canсer, lymph node dissection, older patients, older patients with colon cancer, colorectal cancer surgery, comorbidity



Get access to the full version of this article.

Article Info

Article Type
Research Article
Publication history
Received: Thu 25, Mar 2021
Accepted: Sat 10, Apr 2021
Published: Mon 26, Apr 2021
Copyright
© 2023 Sergey K. Efetov. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JSO.2021.01.05

Author Info

Corresponding Author
Sergey K. Efetov
Coloproctology and Minimally Invasive Surgery Clinic, Department of surgery of N.V. Sklifosovsky Clinical Medicine Institute, I. M. Sechenov First Moscow State Medical University, Moscow, Russia

Figures & Tables



Get access to the full version of this article.

References

1.     Zeber JE, Copeland LA, Hosek BJ, Karnad AB, Lawrence VA et al. (2008) Cancer rates, medical comorbidities, and treatment modalities in the oldest patients. Crit Rev Oncol Hematol 67: 237-242. [Crossref]

2.     Janssen Heijnen MLG, Maas HAAM, Houterman S, Lemmens VEPP, Rutten HJT et al. (2007) Comorbidity in older surgical cancer patients: Influence on patient care and outcome. Eur J Cancer 43: 2179-2193. [Crossref]

3.     Biondi A, Vacante M, Ambrosino I, Cristaldi E, Pietrapertosa G et al. (2016) Role of surgery for colorectal cancer in the elderly. World J Gastrointest Surg 8: 606-613. [Crossref]

4.     Vacante M, Cristaldi E, Basile F, Borzì AM, Biondi A (2019) Surgical approach and geriatric evaluation for elderly patients with colorectal cancer. Updates Surg 71: 411-417. [Crossref]

5.     Tsuchida K, Saeki H, Takahashi S, Kamioka Y, Watanabe H et al. (2017) Appropriate Range of Lymph Node Dissection in Elderly Patients with Colorectal Cancer. Gan To Kagaku Ryoho 44: 1211-1213. [Crossref]

6.     Ceccarelli G, Andolfi E, Biancafarina A, Rocca A, Amato M et al. (2017) Robot-assisted surgery in elderly and very elderly population: our experience in oncologic and general surgery with literature review. Aging Clin Exp Res 29: 55-63. [Crossref]

7.     Gülcü B, Yılmazlar T, Işık Ö, Öztürk E (2018) Colorectal cancer surgery in octogenarians. Turk J Surg 34: 271-275. [Crossref]

8.     Oldani A, Bellora P, Monni M, Amato B, Gentilli S (2017) Colorectal surgery in elderly patients: our experience with DaVinci Xi® System. Aging Clin Exp Res 29: 91-99. [Crossref]

9.     Tsar’kov PV, Nikoda VV, Stamov VI, Markar’ian DR, Tulina IA (2012) The efficacy of the multidisciplinary approach in colorectal cancer surgery in elderly patients. Khirurgiia (Mosk) 4-13. [Crossref]

10.  Kordatou Z, Kountourakis P, Papamichael D (2014) Treatment of older patients with colorectal cancer: A perspective review. Ther Adv Med Oncol 6: 128-140. [Crossref]

11.  Yee KWL, Pater JL, Pho L, Zee B, Siu LL (2003) Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier? J Clin Oncol 21: 1618-1623. [Crossref]

12.  Wan Kim Y (2017) Surgical treatment for colorectal cancer in octogenarians and nonagenarians. J BUON 22: 578-585. [Crossref]

13.  Itatani Y, Kawada K, Sakai Y (2018) Treatment of Elderly Patients with Colorectal Cancer. Biomed Res Int 2018: 2176056. [Crossref]

14.  Visser BC, Keegan H, Martin M, Wren SM (2009) Death after colectomy: It’s later than we think. Arch Surg 144: 1021-1027. [Crossref]

15.  Kornmann VNN, Van Vugt JLA, Smits AB, Van Ramshorst B, Boerma D (2017) The first year after colorectal Surgery in the elderly. Ann Coloproctol 33: 134-138. [Crossref]

16.  Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383. [Crossref]

17.  Каприн АД, Старинский ВВ, Петрова ГВ (2018) Состояние Онкологической Помощи Населению России В 2017 Году М.: МНИОИ им. П.А. Герцена ? филиал ФГБУ «НМИЦ радиологии» Минздрава России.

18.  Ng O, Watts E, Bull CA, Morris R, Acheson A et al. (2016) Colorectal cancer outcomes in patients aged over 85 years. Ann R Coll Surg Engl 98: 216-221. [Crossref]

19.  Turner NJ, Mulley GP, Haward RA, Selby PJ (1999) Cancer in old age--is it inadequately investigated and treated? BMJ 319: 309-312. [Crossref]

20.  Egenvall M, Schubert Samuelsson K, Klarin I, Lökk J, Sjövall A et al. (2014) Management of colon cancer in the elderly: a population-based study. Colorectal Dis 16: 433-441. [Crossref]

21.  Lonardi S, Aschele C, Pasetto LM, Pucciarelli S, Friso ML et al. (2008) Multidisciplinary management is strongly suggested in elderly patients with rectal carcinoma. Aging Health 4: 287-298.

22.  Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291: 2441-2447. [Crossref]

23.  Bos ACRK, Kortbeek D, van Erning FN, Zimmerman DDE, Lemmens VEPP et al. (2019) Postoperative mortality in elderly patients with colorectal cancer: The impact of age, time-trends and competing risks of dying. Eur J Surg Oncol 45: 1575-1583. [Crossref]

24.  Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162: 2269-2276. [Crossref]

25.  Choi SH, Kang HY, Choi SY, Kim MN, Yang JI et al. (2015) Colorectal adenoma is associated with coronary artery calcification in a Korean population. Atherosclerosis 242: 515-520. [Crossref]

26.  Chan AOO, Man HJ, Kwok FL, Morris JS, Siu DCW et al. (2007) Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. J Am Med Assoc 298: 1412-1419. [Crossref]

27.  Wang SC, Schulman Marcus J, Fantauzzi J, Bevington T, Sayegh A et al. (2019) Colon cancer laterality is associated with atherosclerosis and coronary artery disease. J Gastrointest Oncol 10: 30-36. [Crossref]

28.  Van De Poll Franse LV, Haak HR, Coebergh JWW, Janssen Heijnen MLG, Lemmens VEPP (2012) Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: A large population-based analysis. Diabetologia 55: 2163-2172. [Crossref]

29.  Leeds IL, Meyers PM, Enumah ZO, He J, Burkhart RA, Haut ER et al. (2019) Psychosocial Risks are Independently Associated with Cancer Surgery Outcomes in Medically Comorbid Patients. Ann Surg Oncol 26: 936-944. [Crossref]

30.  Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y et al. (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1-42. [Crossref]

31.  Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Color Dis 11: 354-364. [Crossref]

32.  Alhassan N, Yang M, Wong Chong N, Liberman AS, Charlebois P et al. (2019) Comparison between conventional colectomy and complete mesocolic excision for colon cancer: a systematic review and pooled analysis: A review of CME versus conventional colectomies. Surg Endosc 33: 8-18. [Crossref]

33.  West NP, Kobayashi H, Takahashi K, Perrakis A, Weber K et al. (2012) Understanding Optimal Colonic Cancer Surgery: Comparison of Japanese D3 Resection and European Complete Mesocolic Excision With Central Vascular Ligation. J Clin Oncol 30: 1763-1769. [Crossref]

34.  Investigate the Radical Extent of Lymphadenectomy of LAparoscopic Right Colectomy for Colon Cancer(RELARC).

35.  Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON).

36.  Karachun A, Petrov A, Panaiotti L, Voschinin Y, Ovchinnikova T (2019) Protocol for a multicentre randomized clinical trial comparing oncological outcomes of D2 versus D3 lymph node dissection in colonic cancer (COLD trial). BJS Open 3: 288-298. [Crossref]

37.  Lee SD, Lim SB (2009) D3 lymphadenectomy using a medial to lateral approach for curable right-sided colon cancer. Int J Colorectal Dis 24: 295-300. [Crossref]

38.  Uematsu D, Akiyama G, Magishi A (2011) Multimedia article. Radical lymphadenectomy for advanced colon cancer via separation of the mesocolon into two layers as in filleting fish. Surg Endosc 25: 1659-1660. [Crossref]

39.  Aquina CT, Mohile SG, Tejani MA, Becerra AZ, Xu Z et al. (2017) The impact of age on complications, survival, and cause of death following colon cancer surgery. Br J Cancer 116: 389-397. [Crossref]

40.  Kotake K, Honjo S, Sugihara K, Hashiguchi Y, Kato T et al. (2012) Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol 42: 29-35. [Crossref]

41.  Kanemitsu Y, Komori K, Kimura K, Kato T (2013) D3 lymph node dissection in right hemicolectomy with a no-touch isolation technique in patients with colon cancer. Dis Colon Rectum 56: 815-824. [Crossref]

42.  Sahara K, Watanabe J, Ishibe A, Suwa Y, Suwa H et al. (2019) Long-term outcome and prognostic factors for patients with para-aortic lymph node dissection in left-sided colorectal cancer. Int J Colorectal Dis 34: 1121-1129. [Crossref]

43.  Dekker JWT, Van Den Broek CBM, Bastiaannet E, Van De Geest LGM, Tollenaar RAEM et al. (2011) Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol 18: 1533-1539. [Crossref]

44.  Mamidanna R, Almoudaris AM, Faiz O (2012) Is 30-day mortality an appropriate measure of risk in elderly patients undergoing elective colorectal resection? Colorectal Dis 14: 1175-1182. [Crossref]

45.  Hwang DY, Lee GR, Kim JH, Lee YS (2020) Laparoscopic complete mesocolic excision with D3 lymph node dissection for right colon cancer in elderly patients. Sci Rep 10: 12633. [Crossref]

46.  Numata M, Sawazaki S, Aoyama T, Tamagawa H, Sato T et al. (2019) D3 lymph node dissection reduces recurrence after primary resection for elderly patients with colon cancer. Int J Colorectal Dis 34: 621-628. [Crossref]